新生儿低血糖临床规范管理专家共识(2021)

2022-01-15 中华医学会儿科学分会新生儿学组 中国当代儿科杂志

新生儿低血糖高危因素众多,严重持续的低血糖会导致不可逆的神经系统损伤,给家庭及社会带来极大负担。早期规范的预防及临床管理可有效降低新生儿低血糖及低血糖所致脑损伤的发生率。

中文标题:

新生儿低血糖临床规范管理专家共识(2021)

发布日期:

2022-01-15

简要介绍:

新生儿低血糖高危因素众多,严重持续的低血糖会导致不可逆的神经系统损伤,给家庭及社会带来极大负担。早期规范的预防及临床管理可有效降低新生儿低血糖及低血糖所致脑损伤的发生率。然而,目前国内尚无统一的新生儿低血糖临床管理指南,不同医疗机构借鉴不同的国外指南对新生儿低血糖进行临床管理,差异性较大。为进一步规范新生儿低血糖临床管理,由中华医学会儿科学分会新生儿学组制定了该共识。该共识针对胎龄35周及以上新生儿低血糖的预防、监测和管理的相关临床问题提出了21条推荐意见。

相关资料下载:
[AttachmentFileName(sort=1, fileName=新生儿低血糖临床规范管理专家共识(2021).pdf)] GetToolGuiderByIdResponse(projectId=1, id=1ae3e1c0023a2973, title=新生儿低血糖临床规范管理专家共识(2021), enTitle=, guiderFrom=中国当代儿科杂志, authorId=0, author=, summary=新生儿低血糖高危因素众多,严重持续的低血糖会导致不可逆的神经系统损伤,给家庭及社会带来极大负担。早期规范的预防及临床管理可有效降低新生儿低血糖及低血糖所致脑损伤的发生率。, cover=https://img.medsci.cn/202221/1643686740633_1608702.jpg, journalId=0, articlesId=null, associationId=625, associationName=中华医学会儿科学分会新生儿学组, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">新生儿低血糖高危因素众多,严重持续的低血糖会导致不可逆的神经系统损伤,给家庭及社会带来极大负担。早期规范的预防及临床管理可有效降低新生儿低血糖及低血糖所致脑损伤的发生率。然而,目前国内尚无统一的新生儿低血糖临床管理指南,不同医疗机构借鉴不同的国外指南对新生儿低血糖进行临床管理,差异性较大。为进一步规范新生儿低血糖临床管理,由中华医学会儿科学分会新生儿学组制定了该共识。该共识针对胎龄35周及以上新生儿低血糖的预防、监测和管理的相关临床问题提出了21条推荐意见。</span></p>, tagList=[TagDto(tagId=56176, tagName=新生儿低血糖), TagDto(tagId=117862, tagName=新生儿区)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7080, appHits=473, showAppHits=0, pcHits=1796, showPcHits=6605, likes=4, shares=99, comments=10, approvalStatus=1, publishedTime=Tue Feb 01 15:37:00 CST 2022, publishedTimeString=2022-01-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue Feb 01 11:42:00 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 07:18:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=新生儿低血糖临床规范管理专家共识(2021).pdf)])
新生儿低血糖临床规范管理专家共识(2021).pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2175096, encodeId=578421e50962a, content=新生儿低血糖临床管理,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65148644426, createdName=ms4000001195066568, createdTime=Fri Dec 15 14:09:38 CST 2023, time=2023-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231474, encodeId=994712314e4fe, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c825226884, createdName=14790e81m69暂无昵称, createdTime=Sat Jul 09 11:36:47 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204405, encodeId=59f6120440556, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:40:15 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199875, encodeId=410011998e5e9, content=收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b56537663, createdName=ms1000000245239458, createdTime=Sun Mar 06 11:10:32 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197313, encodeId=952d119e31358, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a94f3646482, createdName=133e635am65暂无昵称, createdTime=Fri Feb 25 21:08:32 CST 2022, time=2022-02-25, status=1, ipAttribution=)]
    2023-12-15 ms4000001195066568 来自江苏省

    新生儿低血糖临床管理,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2175096, encodeId=578421e50962a, content=新生儿低血糖临床管理,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65148644426, createdName=ms4000001195066568, createdTime=Fri Dec 15 14:09:38 CST 2023, time=2023-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231474, encodeId=994712314e4fe, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c825226884, createdName=14790e81m69暂无昵称, createdTime=Sat Jul 09 11:36:47 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204405, encodeId=59f6120440556, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:40:15 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199875, encodeId=410011998e5e9, content=收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b56537663, createdName=ms1000000245239458, createdTime=Sun Mar 06 11:10:32 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197313, encodeId=952d119e31358, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a94f3646482, createdName=133e635am65暂无昵称, createdTime=Fri Feb 25 21:08:32 CST 2022, time=2022-02-25, status=1, ipAttribution=)]
    2022-07-09 14790e81m69暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2175096, encodeId=578421e50962a, content=新生儿低血糖临床管理,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65148644426, createdName=ms4000001195066568, createdTime=Fri Dec 15 14:09:38 CST 2023, time=2023-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231474, encodeId=994712314e4fe, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c825226884, createdName=14790e81m69暂无昵称, createdTime=Sat Jul 09 11:36:47 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204405, encodeId=59f6120440556, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:40:15 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199875, encodeId=410011998e5e9, content=收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b56537663, createdName=ms1000000245239458, createdTime=Sun Mar 06 11:10:32 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197313, encodeId=952d119e31358, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a94f3646482, createdName=133e635am65暂无昵称, createdTime=Fri Feb 25 21:08:32 CST 2022, time=2022-02-25, status=1, ipAttribution=)]
    2022-03-20 120c570cm03暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2175096, encodeId=578421e50962a, content=新生儿低血糖临床管理,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65148644426, createdName=ms4000001195066568, createdTime=Fri Dec 15 14:09:38 CST 2023, time=2023-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231474, encodeId=994712314e4fe, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c825226884, createdName=14790e81m69暂无昵称, createdTime=Sat Jul 09 11:36:47 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204405, encodeId=59f6120440556, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:40:15 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199875, encodeId=410011998e5e9, content=收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b56537663, createdName=ms1000000245239458, createdTime=Sun Mar 06 11:10:32 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197313, encodeId=952d119e31358, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a94f3646482, createdName=133e635am65暂无昵称, createdTime=Fri Feb 25 21:08:32 CST 2022, time=2022-02-25, status=1, ipAttribution=)]
    2022-03-06 ms1000000245239458

    收益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2175096, encodeId=578421e50962a, content=新生儿低血糖临床管理,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65148644426, createdName=ms4000001195066568, createdTime=Fri Dec 15 14:09:38 CST 2023, time=2023-12-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231474, encodeId=994712314e4fe, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c825226884, createdName=14790e81m69暂无昵称, createdTime=Sat Jul 09 11:36:47 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204405, encodeId=59f6120440556, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:40:15 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199875, encodeId=410011998e5e9, content=收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b56537663, createdName=ms1000000245239458, createdTime=Sun Mar 06 11:10:32 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197313, encodeId=952d119e31358, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a94f3646482, createdName=133e635am65暂无昵称, createdTime=Fri Feb 25 21:08:32 CST 2022, time=2022-02-25, status=1, ipAttribution=)]
    2022-02-25 133e635am65暂无昵称

    学习

    0